Barbara has led the Pfizer Ventures since joining Pfizer in 2007. The venture team has invested in 65 companies and ten funds pursuing products, technologies and services, relevant to all aspects of Pfizer’s business, since inception in 2004. The team has been successful in fulfilling their goal of providing financial and strategic returns to Pfizer. Her pharmaceutical career started in the immunology division of Smith Kline & French Research Laboratories. She started venture investing in 1993 when she joined their venture capital group, S.R. One, Limited. Barbara received her undergraduate degree from Penn State and Ph.D. from the Medical College of Pennsylvania (now Drexel University School of Medicine.)